CD274 and cancer: Tumor immunotherapy, such as PD-1/PD-L1, CTLA-4 antibody therapy and CAR-T/CAR-NK immune cell therapy, is based on the activation of immune cells, especially T cells, which can kill cancer cells [21,22].